Genome mining and metabolite profiling illuminate the taxonomy status and the cytotoxic activity of a mangrove-derived Microbacterium alkaliflavum sp. nov.

The genus Microbacterium in the phylum Actinomycetota contains over 100 species to date that little is known about their bioactive metabolites production. In this study, a mangrove sediment-derived strain B2969(T) was identified as a novel type strain within the genus Microbacterium due to the low 16S rRNA gene sequence similarity (< 99%), and low overall genome relatedness indices (ANI, 75.4%-79.5%; dDDH, 18.5%-22.7%, AAI, 68.7%-76.3%; POCP, 48.3%-65.0%) with the validly named species of the genus. The type strain B2969(T) (= MCCC 1K099113(T) = JCM 36707( T)) is proposed to represent Microbacterium alkaliflavum sp. nov.. The crude extracts of strain B2969(T) showed weak cytotoxicity against NPC cell lines TW03 and 5-8F, with IC(50) values of ranging from 3.5 µg/µL to 2.4 µg/µL respectively. Genome analysis of strain B2969(T) found 8 clusters of genes responsible for secondary metabolite biosynthesis, including cytotoxic compounds desferrioxamines. In addition, the application of liquid chromatography tandem mass spectrometry (LC-MS/MS)-based molecular networking strategy led to the identification of 10 compounds with potent cytotoxic activity in ethyl acetate extracts of strain B2969(T). Results from the cytotoxicity assay, genome mining, and metabolite profiling based on LC-MS/MS analysis revealed its ability to produce bioactive compounds.BackgroundMangrove ecosystems are largely unexplored sources of Actinomycetota, which represent potential important reservoirs of bioactive compounds. The genus Microbacterium in the phylum Actinomycetota contains over 100 species to date that little is known about their bioactive metabolites production. In this study, a novel species, namely B2969(T), within the genus Microbacterium that showed cytotoxicity against nasopharyngeal carcinoma (NPC) cell lines was isolated from mangrove sediments. Genome mining and metabolic profiling analyses were explored here to assess its biosynthetic potential of metabolites with cytotoxic properties.ResultsHere, a mangrove sediment-derived strain B2969(T) was identified as a novel species within the genus Microbacterium due to the low 16S rRNA gene sequence similarity (< 99.0%), and low overall genome relatedness indices (ANI, 75.4%-79.5%; dDDH, 18.5%-22.7%, AAI, 68.7%-76.3%; POCP, 48.3%-65.0%) with the type strains of this genus. We proposed that strain B2969(T) represents a new species, in which the name Microbacterium alkaliflavum sp. nov. is proposed. The strain showed weak cytotoxicity against NPC cell lines TW03 and 5-8F, with IC(50) values of ranging from 3.512 µg/µL to 2.428 µg/µL respectively. Genome analysis of strain B2969(T) found 8 clusters of genes responsible for secondary metabolite biosynthesis, including desferrioxamines. In addition, the application of liquid chromatography tandem mass spectrometry (LC-MS/MS)-based molecular networking strategy led to the identification of 10 potent cytotoxic compounds in ethyl acetate extracts of strain B2969(T).ConclusionsThis study confirmed the taxonomy status of type strain B2969(T) (= MCCC 1K099113(T) = JCM 36707( T)) within the genus Microbacterium, in which the name Microbacterium alkaliflavum sp. nov.. Results from the cytotoxicity assay, genome mining, and metabolite profiling based on LC-MS/MS analysis revealed its ability to produce bioactive substances, providing sufficient evidence for the potential of Microbacterium species in the discovery of novel pharmaceuticals.